ASB FINANCIAL CP Reported Earnings

ASB FINANCIAL CP (ASBP) reported a loss of $1.00 per share on revenue of $0.06 million for the . .

Aspire Biopharma Inc. is a privately held, early-stage biopharmaceutical technology company. It engaged in the business of developing and marketing a disruptive technology for novel delivery mechanisms for FDA approved drugs, nutraceuticals and supplements. Aspire Biopharma Inc., formerly known as PowerUp Acquisition Corp., is based in NEW YORK.